Bionano Genomics, Inc. financial data

Symbol
BNGO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
9540 Towne Centre Drive, Suite 100, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BioNanomatrix Inc (to 3/24/2011)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % -64%
Quick Ratio 50.5 % -36.9%
Debt-to-equity 61.1 % +224%
Return On Equity -177 % -231%
Return On Assets -110 % -145%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.7M shares -82.1%
Common Stock, Shares, Outstanding 57.5M shares -81.2%
Entity Public Float 201M USD -49.7%
Common Stock, Value, Issued 6K USD -80.6%
Weighted Average Number of Shares Outstanding, Basic 52.7M shares +74.6%
Weighted Average Number of Shares Outstanding, Diluted 52.7M shares +74.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 37.5M USD +26.9%
Research and Development Expense 49.9M USD -4.92%
Costs and Expenses 219M USD +49.1%
Operating Income (Loss) -209M USD -49.4%
Nonoperating Income (Expense) -18.2M USD -1154%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -227M USD -64.5%
Income Tax Expense (Benefit) 18K USD -99.1%
Net Income (Loss) Attributable to Parent -227M USD -62.3%
Earnings Per Share, Basic -6.18 USD/shares -8.42%
Earnings Per Share, Diluted -6.18 USD/shares -8.42%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.8M USD +284%
Accounts Receivable, after Allowance for Credit Loss, Current 8.31M USD +22.6%
Inventory, Net 23.8M USD -28.1%
Other Assets, Current 976K USD -59.5%
Assets, Current 85.6M USD -39.9%
Property, Plant and Equipment, Net 25.3M USD +32.7%
Operating Lease, Right-of-Use Asset 4.87M USD -31%
Intangible Assets, Net (Excluding Goodwill) 31.7M USD -19.4%
Goodwill 0 USD -100%
Other Assets, Noncurrent 6.65M USD +139%
Assets 158M USD -45.9%
Accounts Payable, Current 9.84M USD -37.6%
Employee-related Liabilities, Current 8.76M USD +38%
Accrued Liabilities, Current 11M USD +19.2%
Contract with Customer, Liability, Current 1.04M USD -8.16%
Liabilities, Current 58.5M USD +53.4%
Contract with Customer, Liability, Noncurrent 138K USD -28.9%
Operating Lease, Liability, Noncurrent 2.76M USD -45.4%
Liabilities 75.2M USD +24%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16K USD +97.6%
Retained Earnings (Accumulated Deficit) -613M USD -58.8%
Stockholders' Equity Attributable to Parent 82.8M USD -64.2%
Liabilities and Equity 158M USD -45.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.1M USD +13.2%
Net Cash Provided by (Used in) Financing Activities -21.6M USD -245%
Net Cash Provided by (Used in) Investing Activities 47.6M USD +188%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 57.5M shares -81.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.19M USD -122%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.2M USD +259%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.62M USD +7295%
Deferred Tax Assets, Valuation Allowance 111M USD -9.26%
Deferred Tax Assets, Gross 120M USD -10%
Operating Lease, Liability 4.95M USD -32.1%
Depreciation 6.5M USD +71.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -226M USD -62.9%
Lessee, Operating Lease, Liability, to be Paid 5.49M USD -34.6%
Property, Plant and Equipment, Gross 42.4M USD +36.4%
Operating Lease, Liability, Current 2.19M USD -2.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 544K USD -80.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.61M USD -2.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 546K USD -51.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 254K USD -65.2%
Deferred Tax Assets, Operating Loss Carryforwards 92M USD -16.1%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 62K USD -50%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.99M USD -31.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 669K USD +3.88%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -1K USD -200%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 7.2M USD +24.1%
Depreciation, Depletion and Amortization 3.01M USD -5.74%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.3M USD -32.5%
Interest Expense 5.17M USD +1639%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares